Hp patient monitor

Manufactured by Agilent Technologies

Sourced in United States

The HP Patient Monitor is a medical device designed to continuously monitor a patient's vital signs, including heart rate, blood pressure, and respiratory rate. It provides real-time data to healthcare professionals for patient assessment and care.

Automatically generated - may contain errors

Lab products found in correlation

Finometer, by Finapres Medical Systems (2 mentions)

5 protocols using hp patient monitor

Multimodal Cardiovascular Monitoring Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

Instrumentation for each experiment was identical. Heart rate was continuously obtained from an electrocardiogram (HP Patient Monitor, Agilent, Santa Clara, CA, USA) interfaced with a cardiotachometer (CWE, Ardmore, PA, USA). Continuous beat-by-beat MAP was recorded from a finger using the Penaz method [Finometer; Finapres Medical Systems, Amsterdam, The Netherlands (experiment 1) and the CNAP, Biopac Monitor 500, Bruck an der Mur Austria (experiment 2)] and was corrected according to intermittent blood pressure measurements obtained by auscultation of the brachial artery via electrosphygmomanometry (SunTech, Raleigh, NC, USA). Blood flow in the middle cerebral artery (CBFV) was continuously measured using transcranial Doppler ultrasonography. A 2 MHz Doppler probe (Multi-flow; DWL Elektronische Systeme, Singen, Germany) was adjusted over the temporal window of the right middle cerebral artery until an optimal signal was identified. The probe was then fixed and held in place using a headband strap to prevent subtle movement of the Doppler probe. An index of cerebrovascular conductance (CVCI) was calculated from the ratio of CBFV to MAP. The was measured continuously using a capnograph (VitalCap Capnograph Monitor; Oridion, Needham, MA, USA).

Brothers R.M., Lucas R.A., Zhu Y.S., Crandall C.G, & Zhang R. (2014). Cerebral vasomotor reactivity: steady-state versus transient changes in carbon dioxide tension. Experimental Physiology, 99(11), 1499-1510.

+ Open protocol

+ Expand

Cerebrovascular Hemodynamics Monitoring Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

All data were collected in the supine position. Each subject was instrumented for continuous measurement of heart rate (HR) and cardiac rhythms from an electrocardiogram (HP Patient Monitor; Agilent, Santa Clara, CA, USA) interfaced with a cardiotachometer (CWE, Ardmore, PA, USA). Continuous mean arterial pressure (MAP) was recorded and monitored from a finger using the Penaz method (CNAP, Biopac Monitor 500, Bruck an der Mur, Austria). The CBFV was measured continuously using transcranial Doppler ultrasonography. The right middle cerebral artery was imaged through a 2 MHz Doppler probe (Multi-flow; DWL Elektronische Systeme, Singen, Germany) adjusted over the temporal window until a signal was identified. The probe was fixed securely in place using a head strap to prevent any slight movement of the Doppler probe. The CVCI was calculated from the ratio of CBFV to MAP. End-tidal carbon dioxide tension ( ) was measured continuously using a capnograph, through a mouthpiece, during all data collection periods and was used as an index of (VitalCap Capnograph Monitor; Oridion, Needham, MA, USA).

Hurr C., Kim K., Harrison M.L, & Brothers R.M. (2014). Attenuated cerebral vasodilatory capacity in response to hypercapnia in college-aged African Americans. Experimental Physiology, 100(1), 35-43.

+ Open protocol

+ Expand

Thermoregulation and Cardiovascular Response

Check if the same lab product or an alternative is used in the 5 most similar protocols

Approximately 90 min prior to experimental testing, each subject swallowed a temperature pill (HQ Inc., Palmetto, FL, USA) to measure intestinal temperature. Mean skin temperature was measured from the weighted average of six thermocouples attached to the skin [27 (link)]. Body temperature was controlled via a water-perfused tube lined suit (Med-Eng, Ottawa, ON, Canada) that covered the entire body except the head, hands, and the feet. Heart rate was continually recorded from an electrocardiogram (HP Patient Monitor, Agilent, Santa Clara, CA, USA) interfaced with a cardiotachometer (CWE, Ardmore, PA, USA). Beat-to-beat arterial pressure was continuously measured via the Penaz method (Finometer Pro, FMS, Amsterdam, The Netherlands or NexFin HD, BMEYE B.V., Amsterdam, The Netherlands), with its readings confirmed intermittently via auscultation of the brachial artery by electrosphygmomanometry (Tango+, SunTech, Raleigh, NC, USA). During all experimental trials the subjects were placed into an LBNP box that was sealed at the level of the iliac crest, remaining supine for the duration of the protocol.

Schlader Z.J, & Crandall C.G. (2014). Normothermic central hypovolemia tolerance reflects hyperthermic tolerance. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 24(3), 119-126.

+ Open protocol

+ Expand

Multimodal Cardiovascular and Cerebrovascular Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols

Instrumentation for each aim was identical. Heart rate was continuously obtained from an electrocardiogram (HP Patient Monitor, Agilent, Santa Clara, CA) interfaced with a cardiotachometer (CWE, Ardmore, PA). Continuous beat-by-beat mean arterial blood pressure (MAP) was recorded from a finger using the Penaz method (Finometer, Finapres Medical Systems, Amsterdam, Netherlands (aim #1) and the CNAP, Biopac Monitor 500, Austria (aim #2)) and was corrected according to intermittent blood pressure measurements obtained by auscultation of the brachial artery via electrosphygmomanometry (SunTech, Raleigh, NC). Blood flow in the middle cerebral artery (CBFV) was continuously measured using transcranial Doppler ultrasonography. A 2-MHz Doppler probe (Multi-flow, DWL Elektronische Systeme, Singen, Germany) was adjusted over the temporal window of the right middle cerebral artery until an optimal signal was identified. The probe was then fixed and held in place using a headband strap to prevent subtle movement of the Doppler probe. An index of cerebrovascular conductance (CVCI) was calculated from the ratio of CBFV to MAP. PETCO₂ was continuously measured using a capnograph (VitalCap Capnograph Monitor, Oridion, Needham, MA).

+ Open protocol

+ Expand

Comprehensive Physiological Assessment During LBNP

Check if the same lab product or an alternative is used in the 5 most similar protocols

Upon arrival, subjects immediately ingested a telemetry pill for collection of intestinal temperature (HQ, Palmetto, FL). Assessment of euhydration was determined via urine specific gravity (USG; < 1.02). If USG was greater than 1.02 the trial was canceled and rescheduled. Subjects then dressed in a water perfused, tube-lined suit (Med-End, Ottawa, Canada) that covered the entire body except the head, face, arms, and feet and were placed into a LBNP chamber that was sealed at the iliac crest. Heart rate (HR) was measured with an electrocardiogram (HP Patient Monitor, Agilent, Santa Clara, CA). Beat-by-beat arterial blood pressure was collected from one finger using the Penaz method (CNAP, Monitor 500, Austria). Cerebral perfusion was indexed as blood velocity in the middle cerebral artery (MCA V_mean), which was assessed using transcranial Doppler ultrasonography via the temporal window with a 2 MHz Doppler probe (Multi-flow, DWL Elektronische Systeme, Singen, Germany) that was held securely in place with a head strap. An index of cerebral vascular conductance (CVCi) was calculated from the ratio of MCA V_mean to mean arterial blood pressure (MAP). Arterial carbon dioxide tension was indexed from P_{ET_CO₂} (VitalCap Capnograph Monitor, Oridion, Needham, MA, USA).

Lee J.F., Christmas K.M., Harrison M.L., Kim K., Hurr C, & Brothers R.M. (2014). Cerebral vasoreactivity: impact of heat stress and lower body negative pressure. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 24(3), 135-141.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!